@article{3d697c625605415c85bbe6be2aa62358,
title = "Mavacamten Favorably Impacts Cardiac Structure in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM Cardiac Magnetic Resonance Substudy Analysis",
keywords = "antagonists & inhibitors, cardiac myosins, cardiomyopathy, hypertrophic, drug therapy, magnetic resonance imaging, physiopathology",
author = "Sara Saberi and Nuno Cardim and Mohamad Yamani and Jeanette Schulz-Menger and Wanying Li and Victoria Florea and Sehnert, {Amy J.} and Kwong, {Raymond Y.} and Michael Jerosch-Herold and Ahmad Masri and Anjali Owens and Lakdawala, {Neal K.} and Kramer, {Christopher M.} and Mark Sherrid and Tim Seidler and Andrew Wang and Farbod Sedaghat-Hamedani and Benjamin Meder and Ofer Havakuk and Daniel Jacoby",
note = "Funding Information: The authors thank the patients, the study site coordinators, and the EXPLORER-HCM (Clinical Study to Evaluate Mavacamten [MYK-461] in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy) study team members. Medical writing support was provided by Dr Nicolas Bertheleme of Oxford Phar-maGenesis (Oxford, UK), with funding from MyoKardia.",
year = "2021",
month = feb,
day = "9",
doi = "10.1161/CIRCULATIONAHA.120.052359",
language = "English (US)",
volume = "143",
pages = "606--608",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "6",
}